Literature DB >> 12857427

Age-related changes in ovarian volume, antral follicle counts and basal follicle stimulating hormone levels: comparison between fertile and infertile women.

M Erdem1, A Erdem, K Biberoglu, M Arslan.   

Abstract

Our objective was to compare the relationship between age, basal follicle stimulating hormone (FSH) level and ultrasound-measured mean ovarian volume (MOV) and mean antral follicle counts (MFC) in a group of infertile and fertile women between the ages of 35 and 45 years. Menstrual cycle day 3 serum FSH, MOV and MFC were analyzed in 62 infertile and 53 fertile women. Basal FSH and MFC did not differ between infertile and fertile women, whereas MOV was significantly smaller in infertile women (p < 0.05). In the infertile group, there was a negative correlation between MOV and age (rho = -0.389, p < 0.05), between MOV and basal FSH (rho = 0.495, p < 0.01), and between MFC and age (rho = -0.553, p < 0.01). In the fertile group, there was a strong negative correlation between MOV and basal FSH (rho = -0.631, p < 0.01), and between MFC and basal FSH (rho = -0.710, p < 0.01). Mean basal FSH, MOV and MFC did not differ between subgroups of patients with different causes of infertility. In the infertile group, patients with small ovaries of volume less than 1.8 cm(3) (mean volume -1 SD) had higher mean basal FSH (p < 0.05) and lower MFC (p < 0.01) levels than patients with normal ovarian volume. In conclusion, transvaginal ultrasound (TVU) indices and indirect hormonal parameters of ovarian reserve were similar in infertile and fertile women aged between 35 and 45 years. It is suggested that, in infertile women above 35 years of age, TVU rather than hormonal parameters be preferred, based on our data showing a stronger association between age and TVU indices of ovarian reserve than between age and increase in basal FSH level. Thus, TVU assessment of ovarian volume and antral follicle counts is a practical and cost-effective, if not better, technique for ovarian reserve testing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857427     DOI: 10.1080/gye.17.3.199.205

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  11 in total

1.  Polycystic ovary morphology: age-based ultrasound criteria.

Authors:  Hyun-Jun Kim; Judith M Adams; Jens A Gudmundsson; Gudmundur Arason; Cindy T Pau; Corrine K Welt
Journal:  Fertil Steril       Date:  2017-08-12       Impact factor: 7.329

Review 2.  Use of electroacupuncture and transcutaneous electrical acupoint stimulation in reproductive medicine: a group consensus.

Authors:  Fan Qu; Rong Li; Wei Sun; Ge Lin; Rong Zhang; Jing Yang; Li Tian; Guo-Gang Xing; Hui Jiang; Fei Gong; Xiao-Yan Liang; Yan Meng; Jia-Yin Liu; Li-Ying Zhou; Shu-Yu Wang; Yan Wu; Yi-Jing He; Jia-Yu Ye; Song-Ping Han; Ji-Sheng Han
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

3.  Validation of multi-detector computed tomography as a non-invasive method for measuring ovarian volume in macaques (Macaca fascicularis).

Authors:  Jeryl C Jones; Susan E Appt; Stephen R Werre; Joshua C Tan; Jay R Kaplan
Journal:  Am J Primatol       Date:  2010-06       Impact factor: 2.371

4.  The anti mullerian hormone- a novel marker for assessing the ovarian reserve in women with regular menstrual cycles.

Authors:  V S Kalaiselvi; Saikumar P; Prabhu K; Prashanth Krishna G
Journal:  J Clin Diagn Res       Date:  2012-11-12

5.  Evaluation of ovarian reserve in infertile patients.

Authors:  Mehmet Fırat Mutlu; Ahmet Erdem
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

6.  Follicle number, not assessments of the ovarian stroma, represents the best ultrasonographic marker of polycystic ovary syndrome.

Authors:  Jacob P Christ; Amy D Willis; Eric D Brooks; Heidi Vanden Brink; Brittany Y Jarrett; Roger A Pierson; Donna R Chizen; Marla E Lujan
Journal:  Fertil Steril       Date:  2013-11-01       Impact factor: 7.329

7.  Evaluation of the ovarian reserve function in patients with metabolic syndrome in relation to healthy controls and different age groups.

Authors:  Fevzi Balkan; Nurcan Cetin; Celil Alper Usluogullari; Oguz Kaan Unal; Betul Usluogullari
Journal:  J Ovarian Res       Date:  2014-06-10       Impact factor: 4.234

8.  Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination.

Authors:  Gokalp Oner; Pasa Ulug; Ferhan Elmali
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

9.  Follicle Stimulating Hormone and Anti-Müllerian Hormone among Fertile and Infertile Women in Ile-Ife, Nigeria: Is there A Difference?

Authors:  Temitope Okunola; Kayode Olusegun Ajenifuja; Olabisi Morebise Loto; Afolabi Salawu; Stephen Oluseyi Omitinde
Journal:  Int J Fertil Steril       Date:  2016-11-11

10.  Biomarkers of Ovarian Reserve.

Authors:  William E Roudebush; Wendy J Kivens; Jessica M Mattke
Journal:  Biomark Insights       Date:  2008-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.